CNVIF
Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in Toronto, Canada.
CNVIF (CNVIF) - Net Assets
Latest net assets as of September 2025: $-18.03 Million USD
Based on the latest financial reports, CNVIF (CNVIF) has net assets worth $-18.03 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($12.44 Million) and total liabilities ($30.47 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-18.03 Million |
| % of Total Assets | -144.89% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
CNVIF - Net Assets Trend (2024–2025)
This chart illustrates how CNVIF's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CNVIF (2024–2025)
The table below shows the annual net assets of CNVIF from 2024 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $-18.03 Million | +79.00% |
| 2024-09-30 | $-85.83 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to CNVIF's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2051600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $148.97 Million | % |
| Total Equity | $-18.03 Million | 100.00% |
CNVIF Competitors by Market Cap
The table below lists competitors of CNVIF ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NTT System SA
WAR:NTT
|
$26.68 Million |
|
Vranken-Pommery Monopole S.A.
LSE:0J7D
|
$26.68 Million |
|
Dharmaj Crop Guard Limited
NSE:DHARMAJ
|
$26.68 Million |
|
Chesapeake Gold Corp.
OTCQX:CHPGF
|
$26.69 Million |
|
Avision Inc
TW:2380
|
$26.67 Million |
|
Inmobiliaria Manquehue S.A
SN:MANQUEHUE
|
$26.66 Million |
|
Ailleron S.A.
WAR:ALL
|
$26.65 Million |
|
Sangji Caelum Inc
KQ:042940
|
$26.65 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CNVIF's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -85,833,000 to -18,029,000, a change of 67,804,000.
- Net loss of 20,516,000 reduced equity.
- New share issuances of 22,164,000 increased equity.
- Other factors increased equity by 66,156,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-20.52 Million | -113.79% |
| Share Issuances | $22.16 Million | +122.94% |
| Other Changes | $66.16 Million | +366.94% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares CNVIF's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2024-09-30 | $-1.94 | $0.39 | x |
| 2025-09-30 | $-0.23 | $0.39 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CNVIF utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -224.91%
- • Asset Turnover: 0.73x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2024 | 0.00% | -2018.28% | 0.25x | 0.00x | $-35.03 Million |
| 2025 | 0.00% | -224.91% | 0.73x | 0.00x | $-18.71 Million |
Industry Comparison
This section compares CNVIF's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CNVIF (CNVIF) | $-18.03 Million | 0.00% | N/A | $26.67 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |